CRMD Q4 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24,779-6.6% YoY

Gross Profit

-$21,346-86.1% margin

Operating Income

-$5M-21698.1% margin

Net Income

-$5M-21409.0% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-58.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$453,344

Balance Sheet

Total Assets

$29M

Total Liabilities

$6M

Stockholders' Equity

-$195M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24,779	$26,523	-6.6%
Gross Profit	-$21,346	$4,410	-584.0%
Operating Income	-$5M	$2M	-351.5%
Net Income	-$5M	$2M	-346.9%